期刊文献+

CT在肾癌诊断中的应用 被引量:3

Evaluation of CT in the Diagnosis of Renal Cell Carcinoma
暂未订购
导出
摘要 目的 :比较CT肾癌分期和INSS病理分期的相关性并对影响CT对肾癌分期的影响因素进行探讨 ,总结影响肾癌分期的因素。方法 :运用CT和手术病理及细胞学检查 (INSS分期 )对 1993年 9月~ 2 0 0 2年 8月进行手术治疗的 10 6例肾癌患者进行分期。回顾性地分析本实验组的术前CT资料 ,探讨CT对肾癌诊断和分期的价值。结果 :经术后病理诊断证实 ,本组CT对肾癌的准确率为 91.5 %。按Robson分期标准 ,CT对肾癌各分期的准确率分别为Ⅰ期 :87.5 % ,Ⅱ期 :76 .5 % ,Ⅲa期 :75 % ,Ⅲb期 :6 2 .5 % ,ⅢC期 :70 .0 % ,Ⅳa期 :75 .0 % ,Ⅳb期 :10 0 .0 %。分期错误率为 18.7%。结论 Objective: To compare the surgical stages with pathological stages based on International Neuroblastoma Staging System(INSS) staging and to explore effect of CT on determination of stages of renal cell carcinoma.Methods:the preoperative CT datas in 106 patients from Sept.1993 to Oct.2002 were staged by the surgicohistopathological method based on International Neuroblastoma Staging System(INSS).Results:The accuracy rate of CT diagnosis was 91.5%. The accuracy rate of staging according to Robson criteria :StageⅠ:87.5 %,SⅡ 76.5 %,SⅢa 75 %,SⅢb 62.5 %,SⅢC 70.0 %,SⅣa 75.0 %,SⅣb 100.0 %. The pit falls rate in CT staging was 18.7%. Conclusion: Imaging may be a valuable basis for clinical assessment and pretreatment staging of renal carcinoma.
出处 《江西医学院学报》 2002年第6期170-172,共3页 Acta Academiae Medicinae Jiangxi
关键词 CT 肾癌 诊断 应用 INSS病理分期 Renal carcinoma Computed tomography
  • 相关文献

参考文献5

  • 1Soyer p, Dufresne A, Klein L. renal cell carcinoma of clear type: correlation of CT features with tumor size, architectwral patterns, and pathologic staging[J]. Eur Radiol, 1997,7:224-229.
  • 2Sheths,Scatarige JC,Horton KM,et al Current concepts in the disgnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT[J]. Rsdiographics,2001,21:237-254.
  • 3Siow WY,Yip SK,Ng LG,et al. Renal cell carcinoma:incidental detection and pathological staging[J]. J R Coll Surg Edinb,2000,45(5) :291-295.
  • 4Miles KA, London NJ, Lavelle JM, et al. CT staging of renal carcinoma: a prospective comparison of three dynamic computed tomography techniques[J]. Eur J Radiol, 1991,13( 1 ): 37-42.
  • 5Kopkal,Fisher U,Zoeller G,et al Dual-phase helical CT of the kidney;value of the corticomedullary and nophrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma[J]. AJR AMJ Roentgenol 1997,169 (6) 1573-1578.

同被引文献37

  • 1彭令荣,韩希年,单鸿,邓星河.16层螺旋CT三期动态扫描对肾癌亚型的诊断价值初探[J].临床放射学杂志,2007,26(5):476-480. 被引量:33
  • 2Griffiths TR, Mellon JK. Evolving immunotherapeutic strategies in bladder and renal cancer[J].Postgrad Med J,2004,80(944):320-327.
  • 3Ordonez NG. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: A comparative study[J]. Hum Pathol, 2004,35(6):697-710.
  • 4Clark PE, Hall MC, Miller A, et al.Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma[J].Urology,2004,63(6):1061-1065.
  • 5Kausch I, Jiang H, Brocks C, Bruderek K, Kruger S, Sczakiel G, Jocham D, Bohle A. Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model[J].Eur Urol, 2004,46(1):118-125.
  • 6Rane A, Dasgupta P. The purse-string suture in nephron-sparing surgery for renal cell carcinoma[J].BJU Int,2004,93(9):1361-1362.
  • 7Adiga GU, Dutcher JP, Larkin M,et al.Characterization of bone metastases in patients with renal cell cancer[J].BJU Int,2004,93(9):1237-1240.
  • 8Rini BI, Weinberg V, Small EJ. Practice and progress in kidney cancer: methodology for novel drug development[J].J Urol,2004,171(6 Pt 1):2115-2121.
  • 9Griffiths TR, Mellon JK. Evolving immunotherapeutic strategies in bladder and renal cancer [J]. Postgrad Med J, 2004; 80(944): 320-327.
  • 10Ordonez NG. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: A comparative study [J]. Hum Pathol, 2004; 35(6): 697-710.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部